Groupe D'Etude des Tumeurs Uro-Genitales
1 clinical trials · Sponsor
◉ Watch Groupe D'Etude des Tumeurs Uro-Genitales
| Record | Firm | Date |
|---|---|---|
| Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy (NCT00627354) | Groupe D'Etude des Tumeurs Uro-Genitales | 2006-09-01 |
Track Groupe D'Etude des Tumeurs Uro-Genitales automatically
Every clearance here is in the API, with alerts when new ones post.